(NASDAQ: NOTV) Inotiv's forecast annual revenue growth rate of -0.72% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.25%.
Inotiv's revenue in 2024 is $552,744,000.On average, 1 Wall Street analysts forecast NOTV's revenue for 2024 to be $13,259,983,512, with the lowest NOTV revenue forecast at $13,259,983,512, and the highest NOTV revenue forecast at $13,259,983,512. On average, 1 Wall Street analysts forecast NOTV's revenue for 2025 to be $14,130,286,802, with the lowest NOTV revenue forecast at $14,130,286,802, and the highest NOTV revenue forecast at $14,130,286,802.
In 2026, NOTV is forecast to generate $15,060,324,426 in revenue, with the lowest revenue forecast at $15,060,324,426 and the highest revenue forecast at $15,060,324,426.